广西医学2025，Vol.47Issue(8)：1065-1071,7.DOI:10.11675/j.issn.0253-4304.2025.08.01
中国—东盟卫生合作背景下血液制品产业现状、实现路径和发展前景的探讨
Exploration on current status,realization path,and development prospect of blood product industry under the background of China-ASEAN health cooperation
黄共田 1魏舒 1周云龙 1张翙 1陆祝选 1徐俊1
作者信息
- 1. 上海莱士血液制品股份有限公司,上海市 201403
- 折叠
摘要
Abstract
Blood products play a critical role in the fields such as healthcare,public health,and national defense security.In recent years,China's blood product market has experienced sustained demand growth,yet it faces challenges such as raw material shortages,technological barriers,and import dependency.Leveraging its abundant plasma resources and geographic advantages,Guangxi Zhuang Autonomous Region(hereinafter referred to as Guangxi)has driven transformative industrial development by introducing relevant enterprises and establishing entire industrial chain for blood product production and processing.This paper analyzes the characteristics and current status of the blood product industry,exploring Guangxi's innovative approaches as follows:policy innovation and technology empowerment(e.g.,the"Shanghai research and development+Guangxi production+ASEAN application"model),cross-border collaboration model(ASEAN raw material plasma collection-Guangxi deep processing-ASEAN sales),and positioning Guangxi as the"China-ASEAN Blood Product Research,Development and Production Center",aiming at promoting regional industrial synergy while supporting China's strategic reserve needs for establishing a Southwestern Security Barrier.关键词
血液制品/产业链/血浆加工/生物制药Key words
Blood products/Industrial chain/Plasma processing/Bio-pharmaceuticals分类
医药卫生引用本文复制引用
黄共田,魏舒,周云龙,张翙,陆祝选,徐俊..中国—东盟卫生合作背景下血液制品产业现状、实现路径和发展前景的探讨[J].广西医学,2025,47(8):1065-1071,7.
